Swing Therapeutics was founded in 2019 with the goal of developing digital treatments in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to support the development and validation of its pipeline of prescription-based digital therapies. Swing Therapeutics’ near-term goal is to validate its digital program for the treatment of fibromyalgia and bring it to market as an FDA-cleared, prescription-based digital therapeutic.
Employees: 11-50
Total raised: $19.3M
Founded date: 2019
Investors 3
| Date | Name | Website |
| - | Kicker Ven... | kickervent... |
| - | JAZZ Ventu... | jazzvp.com |
| 25.08.2026 | Endless Fr... | endlessfro... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.06.2022 | Series A | $10.3M | - |
| 11.08.2021 | Seed | $9M | - |
Mentions in press and media 6
| Date | Title | Description |
| 15.07.2026 | XRHealth Acquires Swing Therapeutics to Create Largest Extended Reality Chronic Pain Platform | What You Should Know Extended reality (XR) clinical innovator XRHealth has announced the formal acquisition of digital therapeutics pioneer Swing Therapeutics, making it the largest multi-device XR digital health platform for chronic condit... |
| 15.01.2025 | The Future of Healthcare: AI and XR Revolutionize Patient Care | The healthcare landscape is evolving. Two powerful forces are at the forefront: artificial intelligence (AI) and extended reality (XR). These technologies are not just buzzwords; they are reshaping how we diagnose, treat, and manage health ... |
| 10.01.2025 | Q&A: The state of medical XR in 2025 | Josh Sackman, president and cofounder of AppliedVR Photo courtesy of AppliedVR In November 2021, California-based virtual reality therapeutic company AppliedVR became the first medical extended reality (XR) company to be granted FDA De Novo... |
| 17.06.2022 | Swing Therapeutics Closes $10.3M Series A Funding | Swing Therapeutics, a San Francisco, CA-based digital therapeutics company, raised $10.3M in Series A funding. The round was led by Jazz Venture Partners with participation from Alumni Ventures, AME Cloud Ventures, Asahi Kasei Corporate Ven... |
| 17.06.2022 | Swing Therapeutics raises $10.3M for its digital therapeutic aimed at chronic conditions | Its first products are treatments for fibromyalgia, but it wants to tackle other conditions as well Fibromyalgia isn't a disease that gets talked about much, but there are roughly 10 million people in the US who suffer from it, with the vas... |
| 11.08.2021 | Swing Therapeutics Raises $9M in Seed Funding | Swing Therapeutics, a San Francisco, CA-based digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, raised $9m in seed funding. The round was led by Jazz Venture Partners. The company... |